TLR stimulation during T-cell activation lowers PD-1 expression on CD8 ⁺ T cells

Keyphrases

• CD8+ T Cells 100%
• Tumor Immunity 100%
• T Cell Activation 100%
• TLR Stimulation 100%
• PD-1 Expression 100%
• Programmed Cell Death Protein 1 (PD-1) 100%
• T Cells 66%
• Innate Immune Response 66%
• TLR Agonists 66%
• TLR1 66%
• TLR7 66%
• Tumor Model 33%
• Vaccination 33%
• Effector T Cells 33%
• T Cell Development 33%
• Vaccine Adjuvant 33%
• Therapeutic Vaccine 33%
• Interleukin-12 (IL-12) 33%
• Checkpoint Molecules 33%
• Professional Antigen-presenting Cells 33%
• CD8+ T Cell Infiltration 33%
• TLR9 33%
• Antigen-specific CD8+ T Cells 33%

Immunology and Microbiology

• Cytotoxic T-Cell 100%
• T Cell Activation 100%
• Agonist 50%
• TLR7 50%
• TLR 1 50%
• T Cell 50%
• Antigen 25%
• T Cell Development 25%
• Vaccine Adjuvant 25%
• Antigen-Presenting Cell 25%
• Antigen Specificity 25%
• Immunostimulation 25%
• TLR9 25%
• Cancer Antibody 25%